Patents by Inventor XUDAN BI

XUDAN BI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metalloporphyrin compounds, preparation and uses thereof
    Patent number: 11168096
    Abstract: This disclosure relates to pharmaceutical chemistry, and more particularly to a metalloporphyrin compound, and a preparation and application thereof. The metalloporphyrin compound is shown in formula (I), or an optical isomer, a pharmaceutically-acceptable salt or a solvate thereof, and can specifically recognize the HIV RNA and effectively inhibit HIV reverse transcriptase. This disclosure also provides uses of the compound in the preparation of a reagent for selectively recognizing HIV TAR RNA and a HIV reverse transcriptase inhibitor.
    Type: Grant
    Filed: December 26, 2020
    Date of Patent: November 9, 2021
    Assignee: YUNNAN UNIVERSITY
    Inventors: Feng Gao, Xudan Bi, Yuechen Zhou, Rong Yang, Guokui Li, Yan Li
  • METALLOPORPHYRIN COMPOUNDS, PREPARATION AND USES THEREOF
    Publication number: 20210198287
    Abstract: This disclosure relates to pharmaceutical chemistry, and more particularly to a metalloporphyrin compound, and a preparation and application thereof. The metalloporphyrin compound is shown in formula (I), or an optical isomer, a pharmaceutically-acceptable salt or a solvate thereof, and can specifically recognize the HIV RNA and effectively inhibit HIV reverse transcriptase. This disclosure also provides uses of the compound in the preparation of a reagent for selectively recognizing HIV TAR RNA and a HIV reverse transcriptase inhibitor.
    Type: Application
    Filed: December 26, 2020
    Publication date: July 1, 2021
    Inventors: FENG GAO, XUDAN BI, YUECHEN ZHOU, RONG YANG, GUOKUI LI, YAN LI